Skip to content

Comparison of Er,Cr:YSGG and Diode Lasers In Second Stage Implant Surgery

Clinical Comparison of The Use of Er,Cr:YSGG and Diode Lasers In Second Stage Implant Surgery

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03819244
Enrollment
40
Registered
2019-01-28
Start date
2017-11-27
Completion date
2018-08-20
Last updated
2019-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Pain, Soft Tissue Bleeding, Wound Heal

Keywords

Diode Laser, Erbium Laser, Second-stage Implant Surgery

Brief summary

The study evaluates postoperative pain, intraoperative bleeding and wound healing after second stage implant surgery. Submerged implants were exposed with diode laser in Group 1 (n=20) and by using Er,Cr:YSGG laser in Group 2 (n=20).

Interventions

DEVICE940 nm Gallium Aluminum Arsenide Diode Laser

Exposure of the cover screw of osseointegrated dental implants embedded under oral mucosa by performing the soft tissue incision with diode laser for placing the healing abutment.

Exposure of the cover screw of osseointegrated dental implants embedded under oral mucosa by performing the soft tissue incision with erbium laser for placing the healing abutment.

Sponsors

Yuzuncu Yil University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* subject has osseointegrated implants embedded under oral mucosa. * subject undergoes second-stage implant surgery.

Exclusion criteria

* inadequate keratinized gingiva in the implant site. * localization of the implant site is not possible due to excessive thickness of the oral mucosa

Design outcomes

Primary

MeasureTime frameDescription
Postoperative pain on 1st day1st DayPatients score pain intensity with numeric scale ranging between 0(no pain) to 10(most severe pain) on the postoperative 1st day. Pain scores on the postoperative 1st day in each group are compared.
Postoperative pain on 2nd day2nd DayPatients score pain intensity with numeric scale ranging between 0(no pain) to 10(most severe pain) on the postoperative 2nd day. Pain scores on the postoperative 2nd day in each group are compared.
Postoperative pain on 3rd day3rd DayPatients score pain intensity with numeric scale ranging between 0(no pain) to 10(most severe pain) on the postoperative 3rd day. Pain scores on the postoperative 3rd day in each group are compared.

Secondary

MeasureTime frameDescription
Number of analgesics used daily3 daysAnalgesic consumption per day on postoperative 1st, 2nd and 3rd days.
Intraoperative bleedingDuring operationBleeding during surgical procedure was scored by the physician as 1=minimal, 2=normal and 3=excessive bleeding

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026